Search Results - "Bemelman, F.J."

Prophylaxis by trimethoprim–sulfamethoxazole does not reduce the incidence of severe urinary tract infection but facilitates the development of antimicrobial resistance by Singh, R, Geerlings, S.E, ten Berge, R.J.M, Bemelman, F.J

Get full text

Fast track hand-assisted laparoscopic donor nephrectomy: A randomized clinical trial by Alberts, V.P, Minnee, R.C, Bemelman, F.J, Donselaar-van der Pant, K.A.M.I, Hollman, M, Idu, M.M

Get full text

ABO-incompatible kidney transplantation outcomes: A single centre experience by van Sandwijk, M.S, Bemelman, F.J, Donselaar-van der Pant, K.A.M.I, van der Weerd, N.C, de Jong, T, ten Berge, I.J.M

Get full text

Duplicated Ureters and Renal Transplantation: A Case-Control Study and Review of the Literature by Alberts, V.P, Minnee, R.C, van Donselaar–van der Pant, K.A.M.I, Bemelman, F.J, Zondervan, P.J, Laguna Pes, M.P, Idu, M.M

“…Abstract Introduction Complications of the transplant ureter are the most important cause of surgical morbidity after renal transplantation. The presence of…”
Get full text

CD27bright CD45RAbright CD8 T cells expressing Eomes, T-Bet and Hobit: Naïve T cells losing innocence? by Remmerswaal, E.B.M, van Aalderen, M.C, van der Bom-Baylon, N, van Donselaar-van der Pant, K.A.M.I, Bemelman, F.J, Kragten, N.A.M, Vieira Braga, F.A, ten Brinke, A, van Lier, R.A.W, ten Berge, I.J.M

Get full text

The need for HLA incompatible kidney transplantation: Launch of a new national transplantation program in the Netherlands by Rowshani, A.T, Christiaans, M.H.L, Hilbrands, L.B, Bemelman, F.J, van Zuilen, A.D, Nurmohamed, S.A, Seelen, M.A, de Fijter, J.W, de Leeuw van Weenen, N.J, de Klerk, M, Betjes, M.G.H

Get full text

The effect of CYP3A422 , CYP3A53 and CYP3A combined genotypes on cyclosporine, everolimus and tacrolimus pharmacokinetics in renal transplant recipients by D.J.A.R., Moes, Swen, J.J, den Hartigh, J, van der Straaten, T, Homan van der Heide, J.J, Sanders, J.S, Bemelman, F.J, de Fijter, J.W, Guchelaar, H.-J

Get full text

Risk Factors for Delayed Graft Function After Hand-Assisted Laparoscopic Donor Nephrectomy by Minnee, R.C, Bemelman, W.A, Donselaar-van der Pant, K.A.M.I, Booij, J, ter Meulen, S, ten Berge, I.J.M, Legemate, D.A, Bemelman, F.J, Idu, M.M

“…Abstract Background Delayed graft function (DGF) has a negative effect on the results of living-donor kidney transplantation. Objective To investigate…”
Get full text

First Clinical Experience With Polysol Solution: Pilot Study in Living Kidney Transplantation by Schreinemachers, M.-C.J.M, Bemelman, F.J, Idu, M.M, van Donselaar-van der Pant, K.A.M.I, van de Berg, P.J.E.J, Reitsma, J.B, Legemate, D.A, Florquin, S, ten Berge, I.J.M, Doorschodt, B.M, van Gulik, T.M

“…Abstract In this study, we assessed the safety of the new organ preservation solution polysol solution in the clinical setting of living kidney…”
Get full text

The PROCARE consortium: Towards an improved allocation strategy for kidney allografts by Otten, H.G, Spierings, E, Hack, C.E, van Reekum, F, van Zuilen, A.D, Verhaar, M.C, Bots, M.L, Claas, F.H.J, Roelen, D.L, de Fijter, J.W, Betjes, M.G.H, Seelen, M.A.J, Sanders, J.S.F, Hepkema, B.G, Lambeck, A.J, Bungener, L.B, Roozendaal, C, Tilanus, M.G.J, Vanderlocht, J, Voorter, C.E, Wieten, L, Christiaans, M, Hilbrands, L.B, Baas, M, Joosten, I, Allebes, W.A, van der Meer, A, van Ittersum, F, Nurmohamed, A, Lardy, N.M, Swelsen, W.T, van Donselaar - van der Pant, K.A.M.I, van der Weerd, N.C, ten Berge, R.J.M, Bemelman, F.J, Hoitsma, A.J

Get full text

Donor feces infusion for eradication of Extended Spectrum beta-Lactamase producing Escherichia coli in a patient with end stage renal disease by Singh, R., van Nood, E., Nieuwdorp, M., van Dam, B., ten Berge, I.J.M., Geerlings, S.E., Bemelman, F.J.

Get full text

Meningococcal Sepsis Complicating Eculizumab Treatment Despite Prior Vaccination by Struijk, G. H., Bouts, A. H. M., Rijkers, G. T., Kuin, E. A. C., ten Berge, I. J. M., Bemelman, F. J.

Get full text

DCD donor hemodynamics as predictor of outcome after kidney transplantation by Peters‐Sengers, H., Houtzager, J. H. E., Heemskerk, M. B. A., Idu, M. M., Minnee, R. C., Klaasen, R. W., Joor, S. E., Hagenaars, J. A. M., Rebers, P. M., Heide, J. J. Homan, Roodnat, J. I., Bemelman, F. J.

“…Insufficient hemodynamics during agonal phase—ie, the period between withdrawal of life‐sustaining treatment and circulatory arrest—in Maastricht category III…”
Get full text

The potential beneficial role of faecal microbiota transplantation in diseases other than Clostridium difficile infection by Singh, R., Nieuwdorp, M., ten Berge, I.J.M., Bemelman, F.J., Geerlings, S.E.

“…This review gives an outline of the indications for faecal microbiota transplantation (FMT) for diseases other than Clostridium difficile (C. difficile)…”
Get full text

The Natural History of Clinical Operational Tolerance After Kidney Transplantation Through Twenty‐Seven Cases by Brouard, S., Pallier, A., Renaudin, K., Foucher, Y., Danger, R., Devys, A., Cesbron, A., Guillot‐Guegen, C., Ashton‐Chess, J., Le Roux, S., Harb, J., Roussey, G., Subra, J.‐F., Villemain, F., Legendre, C., Bemelman, F.J., Orlando, G., Garnier, A., Jambon, H., Le Monies De Sagazan, H., Braun, L., Noël, C., Pillebout, E., Moal, M.‐C., Cantarell, C., Hoitsma, A., Ranbant, M., Testa, A., Soulillou, J.‐P., Giral, M.

“…We report here on a European cohort of 27 kidney transplant recipients displaying operational tolerance, compared to two cohorts of matched kidney transplant…”
Get full text

Virus‐Specific CD8+ T Cells Cross‐Reactive to Donor‐Alloantigen Are Transiently Present in the Circulation of Kidney Transplant Recipients Infected With CMV and/or EBV by Heutinck, K. M., Yong, S. L., Tonneijck, L., Heuvel, H., Weerd, N. C., Pant, K. A. M. I., Bemelman, F. J., Claas, F. H. J., Berge, I. J. M.

“…T cells play a dual role in transplantation: They mediate transplant rejection and are crucial for virus control. Memory T cells generated in response to…”
Get full text

Deep sequencing of antiviral T-cell responses to HCMV and EBV in humans reveals a stable repertoire that is maintained for many years by Klarenbeek, P L, Remmerswaal, E B M, ten Berge, I J M, Doorenspleet, M E, van Schaik, B D C, Esveldt, R E E, Koch, S D, ten Brinke, A, van Kampen, A H C, Bemelman, F J, Tak, P P, Baas, F, de Vries, N, van Lier, R A W

“…CD8(+) T-cell responses against latent viruses can cover considerable portions of the CD8(+) T-cell compartment for many decades, yet their initiation and…”
Get full text

Early Conversion to Prednisolone/Everolimus as an Alternative Weaning Regimen Associates With Beneficial Renal Transplant Histology and Function: The Randomized‐Controlled MECANO Trial by Bemelman, F. J., Fijter, J. W., Kers, J., Meyer, C., Peters‐Sengers, H., Maar, E. F., Pant, K. A. M. I., Vries, A. P. J., Sanders, J.‐S., Zwinderman, A., Idu, M. M., Berger, S., Reinders, M. E. J., Krikke, C., Bajema, I. M., Dijk, M. C., Berge, I. J. M., Ringers, J., Lardy, J., Roelen, D., Moes, D.‐J., Florquin, S., Homan van der Heide, J. J.

“…In renal transplantation, use of calcineurin inhibitors (CNIs) is associated with nephrotoxicity and immunosuppression with malignancies and infections. This…”
Get full text

Incidence, risk factors, and the impact of allograft pyelonephritis on renal allograft function by Singh, R., Geerlings, S.E., Peters-Sengers, H., Idu, M.M., Hodiamont, C.J., ten Berge, I.J.M., Bemelman, F.J.

“…Background The impact of allograft pyelonephritis (AGPN) on renal allograft function is controversial. In this study, we evaluated the incidence, risk factors,…”
Get full text

Eculizumab Rescue Therapy in Patients With Recurrent Atypical Hemolytic Uremic Syndrome After Kidney Transplantation by Duineveld, Caroline, Bouwmeester, Romy N., Wijnsma, Kioa L., Bemelman, F.J., van der Heijden, J.W., Berger, S.P., van den Heuvel, L.P.W.J., van de Kar, Nicole C.A.J., Wetzels, Jack F.M., van Zuijlen, A.D., Berger, Dr.SP, Bemelman, F.J., van der Heijden, J.W., van de Wetering, J., de Vries, A.P.J., Wetzels, J.F.M., van Wijk, J.A.E., Bouts, A.H.M., Dorresteijn, E.M., Gracchi, V., Horuz-Engels, F.A.P.T., Keijzer-Veen, M.G., van Rooij, R.W.G., van de Kar, N.C.A.J., van den Heuvel, L.P.

“…Since 2016, kidney transplantation in patients with atypical hemolytic uremic syndrome (aHUS) in the Netherlands is performed without eculizumab prophylaxis…”
Get full text